ES2008580A6 - Forma de dosificacion para la liberacion rapida y lenta de agente beneficioso. - Google Patents

Forma de dosificacion para la liberacion rapida y lenta de agente beneficioso.

Info

Publication number
ES2008580A6
ES2008580A6 ES8802714A ES8802714A ES2008580A6 ES 2008580 A6 ES2008580 A6 ES 2008580A6 ES 8802714 A ES8802714 A ES 8802714A ES 8802714 A ES8802714 A ES 8802714A ES 2008580 A6 ES2008580 A6 ES 2008580A6
Authority
ES
Spain
Prior art keywords
quick
dosage form
slow release
beneficial agent
release sheet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8802714A
Other languages
English (en)
Spanish (es)
Inventor
Maureen L Jordan
Atul Devdatt Ayer
Paul R Magruder
Davil Emil Edgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES2008580A6 publication Critical patent/ES2008580A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES8802714A 1987-09-03 1988-09-02 Forma de dosificacion para la liberacion rapida y lenta de agente beneficioso. Expired ES2008580A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/092,857 US4814181A (en) 1987-09-03 1987-09-03 Dosage form comprising fast agent delivery followed by slow agent delivery

Publications (1)

Publication Number Publication Date
ES2008580A6 true ES2008580A6 (es) 1989-07-16

Family

ID=22235509

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802714A Expired ES2008580A6 (es) 1987-09-03 1988-09-02 Forma de dosificacion para la liberacion rapida y lenta de agente beneficioso.

Country Status (23)

Country Link
US (1) US4814181A (enExample)
JP (1) JPH0196116A (enExample)
KR (1) KR950006216B1 (enExample)
AR (1) AR241676A1 (enExample)
AT (1) AT400296B (enExample)
AU (1) AU612397B2 (enExample)
BE (1) BE1001184A3 (enExample)
CA (1) CA1288016C (enExample)
CH (1) CH676794A5 (enExample)
DE (1) DE3829942A1 (enExample)
DK (1) DK485588A (enExample)
ES (1) ES2008580A6 (enExample)
FI (1) FI884056L (enExample)
FR (1) FR2620025B1 (enExample)
GB (1) GB2209280B (enExample)
IE (1) IE61845B1 (enExample)
IT (1) IT1223798B (enExample)
LU (1) LU87326A1 (enExample)
NL (1) NL8802180A (enExample)
NO (1) NO176902C (enExample)
PT (1) PT88404B (enExample)
SE (1) SE8803084L (enExample)
ZA (1) ZA886435B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039436A3 (es) * 2001-11-06 2004-02-26 Osmotica Costa Rica Sa Composiciones farmaceuticas que contienen oxibutinina

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US4915953A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering acetaminophen or phenylpropanolamine
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5126142A (en) * 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5151093A (en) * 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5240713A (en) * 1991-09-27 1993-08-31 Alza Corporation Dual rate agent delivery device
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
SK279964B6 (sk) * 1991-12-27 1999-06-11 Merck & Co. Dávkovacia forma na riadené uvoľňovanie liečiva a
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
AU3909597A (en) * 1996-08-16 1998-03-06 Alza Corporation Dosage form for providing ascending dose of drug
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
BR0115585A (pt) 2000-11-28 2005-12-13 Fmc Corp Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US8329217B2 (en) * 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
AR041744A1 (es) * 2002-10-31 2005-05-26 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida
US20040089308A1 (en) * 2002-11-13 2004-05-13 Welch Robert A. Cervical ring to deliver medication
ES2380827T3 (es) * 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes
MXPA06003453A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Barra de empuje oros para el suministro controlado de agentes activos.
US7897172B2 (en) * 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US20070190137A1 (en) * 2005-10-07 2007-08-16 Reyes Iran Osmotic dosage form with controlled release and fast release aspects
AU2006318319B2 (en) * 2005-11-18 2013-01-17 Glaxo Group Limited Machine and method for pharmaceutical and pharmaceutical-like product assembly
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
EP2120945A1 (en) * 2007-02-28 2009-11-25 Collegium Pharmaceutical, Inc. Antihistamine combination
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
WO2010129288A2 (en) 2009-04-28 2010-11-11 Proteus Biomedical, Inc. Highly reliable ingestible event markers and methods for using the same
UA109424C2 (uk) * 2009-12-02 2015-08-25 Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
CN102905672B (zh) 2010-04-07 2016-08-17 普罗秋斯数字健康公司 微型可吞服装置
EP2642983A4 (en) 2010-11-22 2014-03-12 Proteus Digital Health Inc DEVICE INGREABLE WITH PHARMACEUTICAL PRODUCT
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
CA2853804C (en) 2011-10-28 2021-06-01 Vitalis Llc Anti-flush compositions
WO2014120669A1 (en) 2013-01-29 2014-08-07 Proteus Digital Health, Inc. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
CN109843149B (zh) 2016-07-22 2020-07-07 普罗秋斯数字健康公司 可摄入事件标记的电磁感测和检测
US10820831B2 (en) 2016-10-26 2020-11-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
KR20180071226A (ko) 2018-06-12 2018-06-27 김성규 관성을 이용한 자동차 연료 절약 장치
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175029C (nl) * 1970-12-23 1984-09-17 Boehringer Sohn Ingelheim Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont.
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4475916A (en) * 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
DK90883A (da) * 1982-03-18 1983-09-19 Merck & Co Inc Beholder til osmotisk afgivelse af et stof eller en stofblanding
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4673405A (en) * 1983-03-04 1987-06-16 Alza Corporation Osmotic system with instant drug availability
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
GB2189702B (en) * 1986-04-30 1989-10-18 Alza Corp Dosage form with improved delivery capability
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039436A3 (es) * 2001-11-06 2004-02-26 Osmotica Costa Rica Sa Composiciones farmaceuticas que contienen oxibutinina
WO2003039519A3 (es) * 2001-11-06 2004-03-25 Osmotica Corp Forma de dosificación de liberación controlada dual

Also Published As

Publication number Publication date
KR950006216B1 (ko) 1995-06-12
ATA214488A (de) 1995-04-15
KR890004684A (ko) 1989-05-09
FI884056A7 (fi) 1989-03-04
FI884056L (fi) 1989-03-04
LU87326A1 (fr) 1989-03-08
NO883837L (no) 1989-03-06
NL8802180A (nl) 1989-04-03
GB8820460D0 (en) 1988-09-28
FR2620025A1 (fr) 1989-03-10
GB2209280A (en) 1989-05-10
US4814181A (en) 1989-03-21
GB2209280B (en) 1991-09-04
PT88404A (pt) 1989-07-31
NO176902B (no) 1995-03-13
AU2152688A (en) 1989-03-09
AU612397B2 (en) 1991-07-11
CA1288016C (en) 1991-08-27
IE61845B1 (en) 1994-11-30
IE882641L (en) 1989-03-03
ZA886435B (en) 1989-05-30
JPH0196116A (ja) 1989-04-14
DK485588A (da) 1989-03-04
SE8803084D0 (sv) 1988-09-02
NO176902C (no) 1995-06-21
FR2620025B1 (fr) 1990-04-20
DK485588D0 (da) 1988-09-01
AR241676A1 (es) 1992-10-30
SE8803084L (sv) 1989-03-04
CH676794A5 (enExample) 1991-03-15
DE3829942A1 (de) 1989-03-16
IT1223798B (it) 1990-09-29
NO883837D0 (no) 1988-08-29
IT8867790A0 (it) 1988-09-02
BE1001184A3 (fr) 1989-08-08
AT400296B (de) 1995-11-27
FI884056A0 (fi) 1988-09-02
PT88404B (pt) 1993-02-26

Similar Documents

Publication Publication Date Title
ES2008580A6 (es) Forma de dosificacion para la liberacion rapida y lenta de agente beneficioso.
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
ES2117146T3 (es) Tableta farmaceutica capaz de liberar una o varias sustancias medicamentosas a diferentes velocidades.
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
ES2056660T3 (es) Forma de dosificacion para pautas de suministro de farmacos variables con el tiempo.
FI924247A7 (fi) Annostusmuoto lääkkeen vapauttamiseksi suoleen
NL186239C (nl) Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DK195490A (da) Dispenser for pulverformige medikamenter
MX9202982A (es) Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen.
ES2125342T3 (es) Esteres y combinaciones de un nitrato organico y de un salicilato.
ES2091970T3 (es) Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales.
ES2037908T3 (es) Un procedimiento para la preparacion de una tableta de capas multiples en una forma de dosificacion unitaria solida.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
ES504858A0 (es) Un procedimiento y su correspondiente dispositivo para acelerar la disolucion de medicamentos liozilizados poco solu- bles a base de proteinas.
ES2054333T3 (es) Forma de dosificacion para administrar un antagonista del calcio.
NL175882C (nl) Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
ES2093779T3 (es) Formulacion farmaceutica que contiene diritromicina.
ES2091031T3 (es) Uso de acido hialuronico para prevenir la reestenosis arterial.
JPS51128438A (en) An antibacterial drug against fish diseases
NL143573B (nl) Werkwijze voor het bereiden van farmacologisch werkzame 1,4-tetrahydro-oxazinen, en van farmaceutische preparaten met een kalmerende en/of analgetische en/of anti-inflammatoire werking, die een of meer van deze verbindingen bevatten.
ES2177103T3 (es) Terapia de combinacion para el tratamiento del sida.
AR001070A1 (es) Forma de aplicación para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas y procedimiento para la elaboración de la forma de aplicación

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-09-02